Jupiter Life Line Hospitals Limited (NSE: JLHL)
1,342.25
-9.70 (-0.72%)
Sep 6, 2024, 3:30 PM IST
JLHL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Operating Revenue | 11,134 | 10,695 | 8,925 | 7,331 | 4,862 | 4,629 |
Other Revenue | 293.44 | 259.82 | 104.2 | 40.21 | 41.06 | - |
Revenue | 11,427 | 10,955 | 9,030 | 7,371 | 4,903 | 4,629 |
Revenue Growth (YoY) | 20.46% | 21.32% | 22.49% | 50.35% | 5.90% | - |
Cost of Revenue | 4,162 | 4,022 | 3,317 | 2,922 | 2,138 | 1,839 |
Gross Profit | 7,265 | 6,933 | 5,713 | 4,450 | 2,764 | 2,790 |
Selling, General & Admin | 2,824 | 2,721 | 2,214 | 45.76 | 9.85 | 14.7 |
Other Operating Expenses | 1,658 | 1,570 | 1,382 | 2,830 | 2,042 | 1,948 |
Operating Expenses | 4,908 | 4,715 | 3,981 | 3,237 | 2,359 | 2,222 |
Operating Income | 2,357 | 2,218 | 1,732 | 1,213 | 405.31 | 568.87 |
Interest Expense | -115.78 | -226.61 | -387.43 | -366.55 | -314.63 | -233.47 |
Interest & Investment Income | - | - | - | - | - | 2.72 |
Earnings From Equity Investments | - | - | - | - | - | 9.75 |
Other Non Operating Income (Expenses) | -36.8 | -36.8 | -35.3 | -72.82 | -75.13 | -19.07 |
EBT Excluding Unusual Items | 2,204 | 1,954 | 1,309 | 773.16 | 15.55 | 328.8 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.09 |
Other Unusual Items | 13.6 | - | -22.04 | -1.98 | - | - |
Pretax Income | 2,218 | 1,954 | 1,287 | 771.18 | 15.55 | 328.89 |
Income Tax Expense | 545.78 | 188.03 | 558.03 | 259.9 | 38.52 | 32.56 |
Net Income | 1,672 | 1,766 | 729.05 | 511.28 | -22.97 | 296.33 |
Preferred Dividends & Other Adjustments | - | - | - | - | -45.35 | 0.05 |
Net Income to Common | 1,672 | 1,766 | 729.05 | 511.28 | 22.38 | 296.29 |
Net Income Growth | 73.36% | 142.25% | 42.59% | - | - | - |
Shares Outstanding (Basic) | 64 | 62 | 52 | 51 | 51 | 51 |
Shares Outstanding (Diluted) | 64 | 62 | 57 | 53 | 51 | 51 |
Shares Change (YoY) | 12.14% | 8.94% | 6.67% | 4.16% | -0.00% | - |
EPS (Basic) | 25.98 | 28.68 | 13.91 | 10.05 | 0.44 | 5.82 |
EPS (Diluted) | 25.98 | 28.68 | 12.95 | 9.65 | 0.44 | 5.82 |
EPS Growth | 54.60% | 121.50% | 34.20% | 2093.19% | -92.44% | - |
Free Cash Flow | - | 292.26 | 399.24 | 452.4 | -1,182 | 456.16 |
Free Cash Flow Per Share | - | 4.75 | 7.06 | 8.54 | -23.23 | 8.97 |
Dividend Per Share | - | 1.000 | - | - | - | - |
Gross Margin | 63.58% | 63.28% | 63.27% | 60.36% | 56.38% | 60.28% |
Operating Margin | 20.63% | 20.24% | 19.18% | 16.45% | 8.27% | 12.29% |
Profit Margin | 14.63% | 16.12% | 8.07% | 6.94% | 0.46% | 6.40% |
Free Cash Flow Margin | - | 2.67% | 4.42% | 6.14% | -24.11% | 9.85% |
EBITDA | 2,787 | 2,638 | 2,115 | 1,572 | 711.11 | 827.98 |
EBITDA Margin | 24.39% | 24.08% | 23.42% | 21.33% | 14.50% | 17.89% |
D&A For EBITDA | 430.24 | 420.79 | 383.01 | 359.48 | 305.81 | 259.11 |
EBIT | 2,357 | 2,218 | 1,732 | 1,213 | 405.31 | 568.87 |
EBIT Margin | 20.63% | 20.24% | 19.18% | 16.45% | 8.27% | 12.29% |
Effective Tax Rate | 24.61% | 9.62% | 43.36% | 33.70% | 247.75% | 9.90% |
Revenue as Reported | 11,427 | 10,955 | 9,030 | 7,371 | 4,903 | 4,648 |
Advertising Expenses | - | 7.53 | 35.32 | 45.76 | 9.85 | 14.7 |
Source: S&P Capital IQ. Standard template. Financial Sources.